MeSH term
Frequency | Condition_Probility | Animals | 20 | 0.0 |
Genes, Tumor Suppressor | 2 | 0.0 |
Humans | 41 | 0.0 |
Comparative Study | 4 | 0.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 37 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Alleles | 10 | 0.0 |
Bipolar Disorder/*genetics | 2 | 1.0 |
Female | 16 | 0.0 |
Gene Frequency | 3 | 0.0 |
Genotype | 9 | 0.0 |
Haplotypes/genetics | 3 | 0.0 |
Linkage Disequilibrium | 6 | 0.0 |
Male | 13 | 0.0 |
Mutation | 2 | 0.0 |
Polymorphism, Single Nucleotide/genetics | 3 | 1.0 |
Proto-Oncogene Proteins/*genetics | 19 | 1.0 |
Receptors, Cell Surface/*genetics | 5 | 1.0 |
Research Support, U.S. Gov't, P.H.S. | 17 | 0.0 |
Trinucleotide Repeats/genetics | 2 | 3.0 |
Variation (Genetics) | 2 | 0.0 |
Base Sequence | 4 | 0.0 |
Major Histocompatibility Complex | 3 | 1.0 |
*Polymorphism, Genetic | 6 | 0.0 |
*Receptors, Cell Surface | 26 | 6.0 |
Adult | 8 | 0.0 |
Case-Control Studies | 6 | 0.0 |
China | 2 | 0.0 |
Genetic Predisposition to Disease | 3 | 0.0 |
Middle Aged | 7 | 0.0 |
*Polymorphism, Single Nucleotide | 5 | 0.0 |
Schizophrenia/ethnology/*genetics | 2 | 18.0 |
*Caenorhabditis elegans Proteins | 2 | 1.0 |
Cell Line | 11 | 0.0 |
Gene Deletion | 2 | 0.0 |
Ligands | 6 | 0.0 |
Luciferases/metabolism | 2 | 0.0 |
Membrane Proteins/*metabolism | 2 | 0.0 |
Models, Genetic | 2 | 0.0 |
Protein Binding | 2 | 0.0 |
Protein Structure, Tertiary | 4 | 0.0 |
Proteins/metabolism | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 6 | 0.0 |
*Signal Transduction | 4 | 0.0 |
Gene Expression Regulation, Developmental | 2 | 0.0 |
In Situ Hybridization | 3 | 0.0 |
Mice | 16 | 0.0 |
Phenotype | 4 | 0.0 |
Signal Transduction | 6 | 0.0 |
Chromosome Mapping | 4 | 0.0 |
Major Histocompatibility Complex/*genetics | 3 | 1.0 |
Amino Acid Sequence | 4 | 0.0 |
Conserved Sequence | 2 | 0.0 |
Endopeptidases/*metabolism | 2 | 1.0 |
Molecular Sequence Data | 5 | 0.0 |
Protein Transport | 2 | 0.0 |
Genetics, Population | 3 | 0.0 |
*Linkage Disequilibrium | 3 | 1.0 |
Microsatellite Repeats | 3 | 0.0 |
Polymorphism, Genetic | 4 | 0.0 |
Schizophrenia/*genetics | 5 | 2.0 |
Scotland | 2 | 5.0 |
Blood Vessels/*embryology | 2 | 15.0 |
Endothelium, Vascular/*metabolism | 2 | 0.0 |
Cell Nucleus/metabolism | 2 | 0.0 |
Membrane Proteins/*physiology | 2 | 1.0 |
Membrane Proteins/*biosynthesis/genetics | 2 | 5.0 |
Proto-Oncogene Proteins/*biosynthesis/genetics | 2 | 2.0 |
*Transcription Factors | 5 | 0.0 |
*Cell Transformation, Neoplastic/genetics | 2 | 25.0 |
Proto-Oncogene Proteins/genetics/*physiology | 3 | 3.0 |
Recombinant Fusion Proteins/biosynthesis | 2 | 0.0 |
Transfection | 3 | 0.0 |
Morphogenesis/physiology | 2 | 6.0 |
Proto-Oncogene Proteins/*physiology | 3 | 1.0 |
Exons/genetics | 3 | 0.0 |
Haplotypes | 2 | 0.0 |
Major Histocompatibility Complex/genetics | 3 | 5.0 |
Morphogenesis | 2 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Proto-Oncogene Proteins/biosynthesis/genetics/*physiology | 3 | 12.0 |
Cell Division | 4 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
Mutation/genetics | 2 | 0.0 |
Sequence Deletion | 2 | 0.0 |
Phylogeny | 2 | 0.0 |
*Major Histocompatibility Complex | 2 | 0.0 |
*Trinucleotide Repeats | 3 | 2.0 |
Japan | 3 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Reference Values | 2 | 0.0 |
Age of Onset | 3 | 0.0 |
Aged | 2 | 0.0 |
*Chromosomes, Human, Pair 6 | 2 | 0.0 |
Odds Ratio | 2 | 0.0 |
